New drug reviewTinidazole: A nitroimidazole antiprotozoal agent
References (85)
Metronidazole
Med Clin North Am
(1988)Trichomonas vaginalis: Resistance to metronidazole
Am J Obstet Gynecol
(1967)- et al.
Trichomoniasis: Trends in diagnosis and management
Am J Obstet Gynecol
(1991) - et al.
Tinidazole prophylaxis in elective abdominal hysterectomy
Int J Gynecol Obstet
(1993) - et al.
Single dose tinidazole prophylaxis in vaginal hysterectomy
Int J Gynaecol Obstet
(1993) - et al.
Guidelines for the management of Helicobacter pylori infections
Am J Gastroenterol
(1998) - et al.
Oral tinidazole treatment during pregnancy and teratogenesis
Int J Gynaecol Obstet
(2003) - et al.
Tinidazole: From protozoa to Helicobacter pylori—the past, present and future of a nitroimidazole with peculiarities
Expert Rev Anti Infect Ther
(2004) - et al.
In vitro effect of tinidazole and furazolidone on metronidazole-resistant Trichomonas vaginalis
Antimicrob Agents Chemother
(1996) - et al.
Metronidazole-resistant vaginal trichomoniasis—an emerging problem
N Engl J Med
(1999)
Tinidazole-microbiology, pharmacology and efficacy in anaerobic infections
Infection
(1983)
Nitroheterocyclic drugs with broad spectrum activity
Parasitol Res
(2003)
Single-dose treatment of vaginal trichomoniasis with tinidazole
East Afr Med J
(1974)
Treatment of giardiasis
Clin Microbiol Rev
(2001)
Effects of metronidazole and tinidazole on NTPDase1 and ecto-5′ nucleotidase from intact cells of Trichomonas vaginalis
FEMS Microbiol Lett
(2003)
In vitro susceptibility of Trichomonas vaginalis to 50 antimicrobial agents
Antimicrob Agents Chemother
(1988)
In vitro studies on the sensitivity of local Entamoeba histolytica to anti-amoebic drugs
Southeast Asian J Trop Med Public Health
(1986)
In vitro susceptibilities of 25 Giardia lamblia isolates of human origin to six commonly used antiprotozoal agents
Antimicrob Agents Chemother
(1985)
Antibacterial activity and pharmacokinetics of nitroimidazoles: A review
Scand J Infect Dis Suppl
(1985)
Comparative activity of metronidazole and tinidazole against Clostridium difcile and Peptostreptococcus anaerobius
Antimicrob Agents Chemother
(1987)
In vitro metronidazole and tinidazole activities against metronidazole resistant strains of Trichomonas vaginalis
Antimicrob Agents Chemother
(2003)
Helicobacter pylori infection in a pediatric population: In vitro susceptibilities to omeprazole and eight antimicrobial agents
Antimicrob Agents Chemother
(1992)
Susceptibilities to different antibiotics of Helicobacter pylori strains isolated from patients at the pediatric medical center of Tehran, Iran
J Clin Microbiol
(2004)
Antimicrobial susceptibilities of Gardnerella vaginalis
Antimicrob Agents Chemother
(1993)
Comparative pharmacokinetics of metronidazole and tinidazole as influenced by administration route
Antimicrob Agents Chemother
(1983)
Pharmacokinetics of tinidazole and metronidazole in women after single large oral doses
Brit J Vener Dis
(1975)
Pharmacokinetics of tinidazole in male and female subjects
J Clin Pharmacol
(1982)
The pharmacokinetics, metabolism and tissue distribution of tinidazole
J Antimicrob Chemother
(1982)
Concentrations of metronidazole and tinidazole in male genital tissues
Antimicrob Agents Chemother
(1985)
Concentrations of metronidazole and tinidazole in female reproductive organs after a single intravenous infusion and after repeated oral administration
Infection
(1984)
Concentrations of tinidazole and metronidazole in serum, saliva and alveolar bone
J Antimicrob Chemother
(1982)
Concentrations of tinidazole in body fluids and tissues in gynaecological patients
Chemotherapy
(1977)
Penetration of the blood brain barrier by metronidazole and tinidazole
J Antimicrob Chemother
(1977)
Identification of human cytochrome P(450)s that metabolise anti-parasitic drugs and predictions of in vivo drug hepatic clearance from in vitrodata
Eur J Clin Pharmacol
(2003)
Pharmacokinetics and metabolism of 14C-tinidazole in humans
J Antimicrob Chemother
(1986)
Tinidazole pharmacokinetics in severe renal failure
Clin Pharmacokinet
(1984)
Pharmacokinetics of tinidazole in chronic renal failure and in patients on hemodialysis
Br J Clin Pharmacol
(1983)
Tinidazole in anaerobic infections: A review of its antibacterial activity, pharmacological properties and therapeutic efficacy
Drugs
(1982)
The treatment of trichomonal vaginitis using a single dose of tinidazole by mouth
East Afr Med J
(1974)
Tinidazole in the treatment of trichomoniasis, giardiasis and amoebiasis. Report of a multicentre study
Drugs
(1978)
Single dose treatment of trichomoniasis
J Int Med Res
(1982)
Cited by (134)
New insights on transition metal coordination compounds with biological active azole and nitroimidazole derivatives
2023, Coordination Chemistry ReviewsSolubility, thermodynamic properties and molecular simulation of tinidazole in fourteen mono-solvents at different temperatures
2022, Journal of Chemical ThermodynamicsCitation Excerpt :Tinidazole (TNZ) [IPUAC: 1-(2-ethylsulfonylethyl)-2-methyl-5-nitroimidazole, CAS number: 19387-91-8, Fig. 1; Molar mass: 247.27 g·mol−1], which belongs to nitroimidazoles and is widely used in the prevention and treatment of anaerobes and protozoal diseases [1,2].
US FDA-Approved Antibiotics During the 21st Century
2022, Encyclopedia of Infection and ImmunitySynthesis of Ag@ZrO<inf>2</inf> nanoparticles: A sensitive electrochemical sensor for determination of antibiotic drug tinidazole
2022, International Journal of Electrochemical Science
Copyright © 2005 Excerpta Medica, Inc. Published by Elsevier Inc. All rights reserved.